These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 12609530

  • 1. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
    Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, Peter JB, Tervaert JW.
    J Immunol Methods; 2003 Mar 01; 274(1-2):27-35. PubMed ID: 12609530
    [Abstract] [Full Text] [Related]

  • 2. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E, Ahlquist D, Ullrich S, Gross WL.
    Rheumatology (Oxford); 2002 Nov 01; 41(11):1313-7. PubMed ID: 12422006
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, Wieslander J.
    Kidney Int; 1998 May 01; 53(5):1230-6. PubMed ID: 9573537
    [Abstract] [Full Text] [Related]

  • 4. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
    Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW.
    Arthritis Rheum; 2000 Sep 01; 43(9):2025-33. PubMed ID: 11014352
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
    Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL.
    Rheumatology (Oxford); 2004 Feb 01; 43(2):174-80. PubMed ID: 14585921
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
    Wong RC, Silvestrini RA, Savige JA, Fulcher DA, Benson EM.
    J Clin Pathol; 1999 Feb 01; 52(2):124-8. PubMed ID: 10396240
    [Abstract] [Full Text] [Related]

  • 7. Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice?
    Baslund B, Segelmark M, Wiik A, Szpirt W, Petersen J, Wieslander J.
    Clin Exp Immunol; 1995 Mar 01; 99(3):486-92. PubMed ID: 7882573
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.
    Damoiseaux JG, Slot MC, Vaessen M, Stegeman CA, Van Paassen P, Tervaert JW.
    J Clin Immunol; 2005 May 01; 25(3):202-8. PubMed ID: 15981084
    [Abstract] [Full Text] [Related]

  • 9. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
    Sun J, Fass DN, Hudson JA, Viss MA, Wieslander J, Homburger HA, Specks U.
    J Immunol Methods; 1998 Feb 01; 211(1-2):111-23. PubMed ID: 9617836
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
    van der Geld YM, Oost-Kort W, Limburg PC, Specks U, Kallenberg CG.
    J Immunol Methods; 2000 Oct 20; 244(1-2):117-31. PubMed ID: 11033024
    [Abstract] [Full Text] [Related]

  • 14. Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis.
    Gisslén K, Wieslander J, Westberg G, Herlitz H.
    J Intern Med; 2002 Feb 20; 251(2):129-35. PubMed ID: 11905588
    [Abstract] [Full Text] [Related]

  • 15. Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener's granulomatosis.
    Feng Z, Liu P, Li Z, Sui B.
    J Clin Lab Anal; 2008 Feb 20; 22(1):73-6. PubMed ID: 18200577
    [Abstract] [Full Text] [Related]

  • 16. Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis.
    Segelmark M, Phillips BD, Hogan SL, Falk RJ, Jennette JC.
    Clin Diagn Lab Immunol; 2003 Sep 20; 10(5):769-74. PubMed ID: 12965902
    [Abstract] [Full Text] [Related]

  • 17. The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs.
    Trevisin M, Neeson P, Savige J.
    J Clin Pathol; 2004 Mar 20; 57(3):303-8. PubMed ID: 14990605
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
    Baslund B, Petersen J, Permin H, Wiik A, Wieslander J.
    J Immunol Methods; 1994 Oct 14; 175(2):215-25. PubMed ID: 7930650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.